CAAS Capital Management’s Evotec EVO Stock Holding History

CAAS Capital Management’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-127,903	Closed	-$3.04M	–	746
2021 Q4	$3.04M	Buy	+127,903	New	+$2.98M	0.07%	255

Other funds holding EVO

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CAAS Capital Management's EVO Position: Q1 2022 in Review

CAAS Capital Management sold out of Evotec (EVO) in Q1 2022, closing a stake of 127,903 shares — an estimated $3.04M sold.

CAAS Capital Management first reported a position in EVO in Q4 2021 and held it in 1 quarter. The position peaked at $3.04M in Q4 2021. 22 funds tracked by Wall St. Rank hold EVO as of Q1 2022.

CAAS Capital Management reported no remaining Evotec position as of Q1 2022 after selling out during the quarter.
CAAS Capital Management sold 127,903 Evotec shares in Q1 2022, an estimated $3.04M.
CAAS Capital Management first reported a position in Evotec in Q4 2021 and held it in 1 quarter.
CAAS Capital Management's Evotec position peaked at $3.04M in Q4 2021.
22 funds tracked by Wall St. Rank held Evotec as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.